-
Mashup Score: 0Watch-and-Wait in Rectal Cancer: Study Illuminates What Could Be At Risk | Cancer Nursing Today - 21 day(s) ago
Development of local regrowth after a watch-and-wait period is a “significant and independent” risk factor for subsequent distant metastases (DM) in patients with rectal cancer.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Martha Raymond, MA, of the GI Cancers Alliance, discusses eye-opening findings from a study presented at the 2024 ASCO GI Cancers Symposium.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers - 1 month(s) ago
Development of medicines in rare oncologic patient populations are growing, but well-powered randomized controlled trials are typically extremely challenging or unethical to conduct in such settings. External control arms using real-world data are … Plain language summary Doctors and biomedical researchers are working hard to develop new medicines for rare types of cancer, but conducting traditional, strong clinical trials can be very difficult or even wrong in these cases. To help with this, … Tweetable abstract Navigating the complexities of cancer research in rare cases is challenging. Real-world data comparison is a game-changer, but it comes with hurdles. Enter Quantitative Bias Analysis – a tool that helps us understand and correct errors …
Source: becarispublishing.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers - 2 month(s) ago
Development of medicines in rare oncologic patient populations are growing, but well-powered randomized controlled trials are typically extremely challenging or unethical to conduct in such settings. External control arms using real-world data are … Plain language summary Doctors and biomedical researchers are working hard to develop new medicines for rare types of cancer, but conducting traditional, strong clinical trials can be very difficult or even wrong in these cases. To help with this, … Tweetable abstract Navigating the complexities of cancer research in rare cases is challenging. Real-world data comparison is a game-changer, but it comes with hurdles. Enter Quantitative Bias Analysis – a tool that helps us understand and correct errors …
Source: becarispublishing.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6BESPOKE CRC Trial Provides Insights on How Patients Feel About Serial ctDNA Testing | Cancer Nursing Today - 2 month(s) ago
An analysis from thetrial may be the first to illuminate the “important dimensions of patient well-being and perceived utility of ctDNA testing” in patients with colorectal cancer.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 2 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6ASCO Gastrointestinal Cancers Symposium 2024 - 3 month(s) ago
Important new studies with the potential to impact clinical practice were presented at the 2024 ASCO Gastrointestinal Cancers Symposium held January 18
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Watch-and-Wait in Rectal Cancer: Study Illuminates What Could Be At Risk | Cancer Nursing Today - 3 month(s) ago
Development of local regrowth after a watch-and-wait period is a “significant and independent” risk factor for subsequent distant metastases (DM) in patients with rectal cancer.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0How an Online Quiz and Live Navigation Framework Can Promote CRC Screening | Cancer Nursing Today - 3 month(s) ago
A digital screening tool and live navigation framework could serve as a “key solution” in driving colorectal cancer (CRC) screening.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10Updated CheckMate 649 Data Reinforce Nivolumab Plus Chemo as Frontline SOC in Advanced Gastric Cancers - 3 month(s) ago
Kohei Shitara, MD, discusses 4-year survival data of chemotherapy plus nivolumab in advanced gastric/GEJ cancer or esophageal adenocarcinoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Development of local regrowth after a watch-and-wait period is a “significant and independent” risk factor for subsequent distant metastases in rectal cancer, according to research presented at #GI24 by a team from @ChampalimaudF. ➡️ Learn more: https://t.co/a9SX3pSW3f https://t.co/pLdsPnpKhl